Search Results - Danforth, Dailan

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumors

    Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumors by Heath, Elisabeth I., Weise, Amy, Vaishampayan, Ulka, Danforth, Dailan, Ungerleider, Richard S., Urata, Yasuo

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Outcomes of Second-Line (2L) Triplet+ Regimens in Patients with Relapsed/Refractory Multiple Myeloma (MM) Following Progression after First-Line (1L) Lenalidomide in the Connect® MM Disease Registry

    Outcomes of Second-Line (2L) Triplet+ Regimens in Patients with Relapsed/Refractory Multiple Myeloma (MM) Following Progression after First-Line (1L) Lenalidomide in the Connect® M... by Lee, Hans C., Abonour, Rafat, Ailawadhi, Sikander, Durie, Brian G.M., Gasparetto, Cristina J., Hardin, James W., Narang, Mohit, Omel, James, Rifkin, Robert M., Terebelo, Howard, Toomey, Kathleen, Wagner, Lynne I., Slaff, Samantha, Danforth, Dailan, Chung, Weiyuan, Anand, Jasmeet, Yu, Edward, Tang, Derek, Jagannath, Sundar

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: